After early and regular cART treatment, there were no significant changes in CD4 T cell counts or DTI metrics, suggesting that absolute CD4 T cell counts may not accurately reflect the risks to HIV-infected individuals because immune dysfunction persists even when CD4 counts are back to normal (73). This evidence concerns the gene CD4 and immune system disorder.